Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04229888 · ClinicalTrials.gov registry record · NA
Meibomian Gland Dysfunction Treatment
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04229888 is a NA study that has completed, run by Indiana University. The registered enrollment target is 14 participants.
The verdict
NCT04229888, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of treatments for Meibomian Gland Dysfunction.
Interventions
- DEVICE LipiFlow
- DEVICE Light Based (Sham) Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-02-26 |
| Est. Completion | 2021-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04229888
The ClinicalTrials.gov registry entry for NCT04229888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LipiFlow is the first listed.
NCT04229888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04229888 about?
NCT04229888 is a clinical study titled "Meibomian Gland Dysfunction Treatment". The purpose of this study is to evaluate the effectiveness of treatments for Meibomian Gland Dysfunction.
What is the current status of trial NCT04229888?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-02-26. Estimated completion is 2021-03-25.
What interventions are being tested in trial NCT04229888?
The interventions under investigation include: LipiFlow (DEVICE), Light Based (Sham) Treatment (DEVICE).
Who is sponsoring clinical trial NCT04229888?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.